BALTIMORE, Aug. 19, 2021 /PRNewswire/ — Empower Therapeutics Inc., a Baltimore-based startup, has secured worldwide, exclusive rights to a simple, reliable brainwave biomarker for pain sensitivity. Empower plans to leverage the technology, which is jointly owned by the University of Maryland, Baltimore (UMB) and the University of Birmingham, U.K., to develop a cutting-edge digital therapeutics platform to determine and modify pain sensitivity for chronic pain therapy.
{iframe}https://www.prnewswire.com/news-releases/empower-therapeutics-inc-granted-exclusive-license-to-develop-digital-therapeutics-platform-for-neuromodulation-of-pain-sensitivity-301357873.html?tc=eml_cleartime{/iframe}